Evan D. Morris

6.5k total citations
120 papers, 3.1k citations indexed

About

Evan D. Morris is a scholar working on Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Evan D. Morris has authored 120 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cellular and Molecular Neuroscience, 46 papers in Radiology, Nuclear Medicine and Imaging and 30 papers in Molecular Biology. Recurrent topics in Evan D. Morris's work include Medical Imaging Techniques and Applications (42 papers), Neurotransmitter Receptor Influence on Behavior (36 papers) and Neuroscience and Neuropharmacology Research (25 papers). Evan D. Morris is often cited by papers focused on Medical Imaging Techniques and Applications (42 papers), Neurotransmitter Receptor Influence on Behavior (36 papers) and Neuroscience and Neuropharmacology Research (25 papers). Evan D. Morris collaborates with scholars based in United States, Türkiye and United Kingdom. Evan D. Morris's co-authors include Karmen K. Yoder, Kelly Cosgrove, Marc D. Normandin, Charles A. Bouman, Nabeel Nabulsi, Nathaniel M. Alpert, Mustafa E. Kamaşak, Alan J. Fischman, Ronald E. Fisher and K. Sauer and has published in prestigious journals such as Journal of Neuroscience, NeuroImage and Biological Psychiatry.

In The Last Decade

Evan D. Morris

114 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan D. Morris United States 34 1.2k 990 788 589 303 120 3.1k
Jean‐Dominique Gallezot United States 32 902 0.8× 744 0.8× 619 0.8× 580 1.0× 394 1.3× 109 2.9k
Wolfgang Weber‐Fahr Germany 30 1.1k 0.9× 765 0.8× 1.4k 1.8× 326 0.6× 283 0.9× 81 3.0k
Stephen J. Sawiak United Kingdom 31 879 0.8× 480 0.5× 528 0.7× 608 1.0× 280 0.9× 95 2.5k
Reza Momenan United States 33 1.1k 0.9× 432 0.4× 1.3k 1.6× 372 0.6× 300 1.0× 104 3.7k
Paul D. Acton United States 34 1.2k 1.0× 1.2k 1.2× 572 0.7× 731 1.2× 122 0.4× 83 3.8k
N. Scott Mason United States 31 1.1k 1.0× 498 0.5× 610 0.8× 659 1.1× 489 1.6× 76 2.9k
Graham E. Searle United Kingdom 29 1.0k 0.9× 627 0.6× 576 0.7× 722 1.2× 228 0.8× 76 2.6k
Masanori Ichise United States 31 1.0k 0.9× 869 0.9× 428 0.5× 503 0.9× 274 0.9× 62 3.3k
Mika Naganawa United States 33 1.3k 1.1× 1.1k 1.1× 641 0.8× 891 1.5× 699 2.3× 137 3.6k
Ruth Tuura Switzerland 34 867 0.7× 1.3k 1.3× 1.2k 1.5× 328 0.6× 328 1.1× 127 3.9k

Countries citing papers authored by Evan D. Morris

Since Specialization
Citations

This map shows the geographic impact of Evan D. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan D. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan D. Morris more than expected).

Fields of papers citing papers by Evan D. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan D. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan D. Morris. The network helps show where Evan D. Morris may publish in the future.

Co-authorship network of co-authors of Evan D. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Evan D. Morris. A scholar is included among the top collaborators of Evan D. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan D. Morris. Evan D. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Evan D., Lee Jussim, Peggy Mason, & Sally L. Satel. (2025). Science Is the Thing. Why and How to Restore Balance Between U.S. Institutional Review Boards and Investigators. 5(2). 1–1.
2.
Zhukovsky, Peter, Maria Ironside, Maëva Dhaynaut, et al.. (2024). Acute Stress Increases Striatal Connectivity With Cortical Regions Enriched for μ and κ Opioid Receptors. Biological Psychiatry. 96(9). 717–726. 3 indexed citations
3.
4.
Zakiniaeiz, Yasmin, Ralitza Gueorguieva, Walter Roberts, et al.. (2022). Lower Dopamine D2/3 Receptor Availability is Associated With Worse Verbal Learning and Memory in People Who Smoke Cigarettes. Nicotine & Tobacco Research. 25(5). 1047–1051. 5 indexed citations
5.
Laat, Bart de, et al.. (2021). EC50 images, a novel endpoint from PET target occupancy studies, reveal spatial variation in apparent drug affinity. European Journal of Nuclear Medicine and Molecular Imaging. 49(4). 1232–1241. 4 indexed citations
6.
Groman, Stephanie M., Ansel T. Hillmer, Krista Fowles, et al.. (2020). Midbrain D3 Receptor Availability Predicts Escalation in Cocaine Self-administration. Biological Psychiatry. 88(10). 767–776. 15 indexed citations
7.
Groman, Stephanie M., Ansel T. Hillmer, Krista Fowles, et al.. (2020). Dysregulation of Decision Making Related to Metabotropic Glutamate 5, but Not Midbrain D3, Receptor Availability Following Cocaine Self-administration in Rats. Biological Psychiatry. 88(10). 777–787. 12 indexed citations
8.
Laat, Bart de, Nabeel Nabulsi, Yiyun Huang, et al.. (2020). Occupancy of the kappa opioid receptor by naltrexone predicts reduction in drinking and craving. Molecular Psychiatry. 26(9). 5053–5060. 16 indexed citations
9.
Castrellon, Jaime J., Mikella A Green, Jennifer L. Crawford, et al.. (2019). Reproducibility of the correlative triad among aging, dopamine receptor availability, and cognition.. Psychology and Aging. 34(7). 921–932. 13 indexed citations
10.
Morris, Evan D.. (2017). An Appreciation of The Gene: An Intimate History by Siddhartha Mukherjee and a Call for Expanded Training in the Responsible Conduct of Research.. PubMed. 90(4). 661–665. 1 indexed citations
11.
Hansen, Søren B., Galith Abourbeh, Maqsood Yaqub, et al.. (2017). A multi species evaluation of the radiation dosimetry of [ 11 C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor. Nuclear Medicine and Biology. 47. 56–61. 6 indexed citations
12.
Groman, Stephanie M., Nathaniel J. Smith, Lihui Chen, et al.. (2016). Dopamine D 3 Receptor Availability Is Associated with Inflexible Decision Making. Journal of Neuroscience. 36(25). 6732–6741. 28 indexed citations
13.
Zheng, Ming‐Qiang, Nabeel Nabulsi, Su Kim, et al.. (2013). Synthesis and Evaluation of11C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging. Journal of Nuclear Medicine. 54(3). 455–463. 75 indexed citations
14.
Kim, Su Jin, Ming‐Qiang Zheng, Nabeel Nabulsi, et al.. (2013). Determination of the In Vivo Selectivity of a New κ-Opioid Receptor Antagonist PET Tracer 11C-LY2795050 in the Rhesus Monkey. Journal of Nuclear Medicine. 54(9). 1668–1674. 30 indexed citations
15.
Morris, Evan D., et al.. (2010). Noninvasive visualization of human dopamine dynamics from PET images. NeuroImage. 51(1). 135–144. 20 indexed citations
16.
Yoder, Karmen K., Cristian Constantinescu, David A. Kareken, et al.. (2007). Heterogeneous Effects of Alcohol on Dopamine Release in the Striatum: A PET Study. Alcoholism Clinical and Experimental Research. 31(6). 965–973. 63 indexed citations
17.
Yoder, Karmen K., David A. Kareken, Regat Seyoum, et al.. (2005). Dopamine D2 Receptor Availability is Associated with Subjective Responses to Alcohol. Alcoholism Clinical and Experimental Research. 29(6). 965–970. 67 indexed citations
18.
Matochik, John A., Svetlana I. Chefer, Mark A. Lane, et al.. (2000). Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging. Neurobiology of Aging. 21(4). 591–598. 50 indexed citations
19.
Goyer, Peter F., Marc S. Berridge, Evan D. Morris, et al.. (1996). PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics.. PubMed. 37(7). 1122–7. 31 indexed citations
20.
Semple, William E., Peter F. Goyer, Richard A. McCormick, et al.. (1993). Preliminary report: Brain blood flow using PET in patients with posttraumatic stress disorder and substance-abuse histories. Biological Psychiatry. 34(1-2). 115–118. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Dominique Gallezot Breakdown of academic impact, for papers by Wolfgang Weber‐Fahr Breakdown of academic impact, for papers by Stephen J. Sawiak Breakdown of academic impact, for papers by Reza Momenan Breakdown of academic impact, for papers by Paul D. Acton Breakdown of academic impact, for papers by N. Scott Mason Breakdown of academic impact, for papers by Graham E. Searle Breakdown of academic impact, for papers by Masanori Ichise Breakdown of academic impact, for papers by Mika Naganawa Breakdown of academic impact, for papers by Ruth Tuura
Rankless by CCL
2026